Sagespring Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.38M Sell
24,981
-3,986
-14% -$1.18M 0.13% 91
2025
Q4
$7.91M Buy
28,967
+1,409
+5% +$383K 0.14% 87
2025
Q3
$7.45M Buy
27,558
+2,143
+8% +$583K 0.15% 80
2025
Q2
$7.01M Buy
25,415
+997
+4% +$271K 0.15% 78
2025
Q1
$6.48M Buy
24,418
+52
+0.2% +$12.8K 0.16% 74
2024
Q4
$5.66M Buy
+24,366
New +$5.6M 0.15% 67

Other funds holding CME

Sagespring Wealth Partners's CME Position: Q1 2026 in Review

Sagespring Wealth Partners reduced its CME Group (CME) stake by 14% in Q1 2026, selling an estimated $1.18M and leaving 24,981 shares worth $7.38M. The position accounts for 0.13% of the portfolio, ranked #91.

Sagespring Wealth Partners first reported a position in CME in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.91M in Q4 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Sagespring Wealth Partners held 24,981 shares of CME Group worth $7.38M as of Q1 2026.
  • Sagespring Wealth Partners sold 3,986 CME Group shares in Q1 2026, an estimated $1.18M.
  • CME Group made up 0.13% of Sagespring Wealth Partners's portfolio in Q1 2026, its #91 holding.
  • Sagespring Wealth Partners first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's CME Group position peaked at $7.91M in Q4 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.